
DAPASUG-VD-100
MRP: 2,550
Packaging: 10x10
Pack Type: tablet
Composition:
Dapagliflozin 10mg & Vildagliptin 100mg (Bilayered in Sustained Release Tablet)
Indication:
TYPE 2 DIABETES
Description:
Dapagliflozin 10mg & Vildagliptin 100mg Bilayered Sustained Release Tablet is a dual-action, once-daily oral antidiabetic formulation used in the treatment of type 2 diabetes mellitus. It combines:
Dapagliflozin (10mg): An SGLT2 inhibitor that lowers blood glucose by increasing urinary glucose excretion.
Vildagliptin (100mg, SR): A DPP-4 inhibitor that enhances incretin levels, promoting insulin secretion and suppressing glucagon production.
The bilayered sustained release technology ensures a controlled and prolonged release of Vildagliptin, providing consistent glycemic control throughout the day, while Dapagliflozin acts promptly for early glucose regulation. This combination effectively lowers HbA1c, improves fasting and postprandial glucose levels, and supports weight reduction.
Tags:
- Dual mechanism for optimal glycemic control
- Sustained release technology for consistent drug levels
- Reduces HbA1c, fasting, and post-meal glucose
- Aids in weight loss and lowers blood pressure
- Low risk of hypoglycemia when not used with sulfonylureas or insulin
- Convenient once-daily dosing for better adherence
Usage Information
Dosage
Recommended Dose: One tablet daily or as prescribed Administration: Oral, with or without food Special Instructions: Swallow whole; do not crush or chew Important: Follow the exact dosage schedule prescribed by your physician
Side Effects
Genital fungal infections Urinary tract infections Headache Dizziness Hypoglycemia (if combined with insulin or sulfonylureas) Dehydration or increased urination Nausea or gastrointestinal upset Rare risk of pancreatitis or liver enzyme elevation Seek medical help if you experience allergic reactions, symptoms of ketoacidosis, or severe infections.
Contraindications
Type 1 diabetes mellitus Diabetic ketoacidosis Severe renal impairment or end-stage kidney disease Hypersensitivity to Dapagliflozin, Vildagliptin, or excipients Severe liver dysfunction (especially for Vildagliptin) History of urinary tract or genital infections (use with caution)